We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Analysis: Restricting Medicare Part D Generics to Generic Coverage Tiers Could Save Patients Billions
Analysis: Restricting Medicare Part D Generics to Generic Coverage Tiers Could Save Patients Billions
A proposed Centers for Medicare & Medicaid Services requirement that Medicare Part D plans place generics only on generic formulary tiers could have lowered patients’ drug costs by almost $16 billion over a three-year period, according to an analysis by healthcare consulting firm Avalere.